Skip to main content Back to Top
Advertisement

3/17/2024

Amoxicillin Oral Presentations

Products Affected - Description

    • Amoxicillin oral capsule, Hikma, 500 mg, bottle, 500 count, NDC 00143-9939-05
    • Amoxicillin oral powder for suspension, Hikma, 125 mg/5 mL, 100 mL bottle, NDC 00143-9888-01
    • Amoxicillin oral powder for suspension, Hikma, 125 mg/5 mL, 150 mL bottle, NDC 00143-9888-15
    • Amoxicillin oral powder for suspension, Hikma, 125 mg/5 mL, 80 mL bottle, NDC 00143-9888-80
    • Amoxicillin oral powder for suspension, Hikma, 200 mg/5 mL, 100 mL bottle, NDC 00143-9886-01
    • Amoxicillin oral powder for suspension, Hikma, 200 mg/5 mL, 50 mL bottle, NDC 00143-9886-50
    • Amoxicillin oral powder for suspension, Hikma, 200 mg/5 mL, 75 mL bottle, NDC 00143-9886-75
    • Amoxicillin oral powder for suspension, Hikma, 250 mg/5 mL, 100 mL bottle, NDC 00143-9889-01
    • Amoxicillin oral powder for suspension, Hikma, 250 mg/5 mL, 150 mL bottle, NDC 00143-9889-15
    • Amoxicillin oral powder for suspension, Hikma, 250 mg/5 mL, 80 mL bottle, NDC 00143-9889-80
    • Amoxicillin oral powder for suspension, Hikma, 400 mg/5 mL, 100 mL bottle, NDC 00143-9887-01
    • Amoxicillin oral powder for suspension, Hikma, 400 mg/5 mL, 50 mL bottle, NDC 00143-9887-50
    • Amoxicillin oral powder for suspension, Hikma, 400 mg/5 mL, 75 mL bottle, NDC 00143-9887-75
    • Amoxicillin tablet, Hikma, 875 mg, 100 count, NDC 00143-9285-01
    • Amoxicillin oral capsule, Sandoz, 250 mg, bottle, 100 count, NDC 00781-2020-01
    • Amoxicillin oral capsule, Sandoz, 250 mg, bottle, 500 count, NDC 00781-2020-05
    • Amoxicillin oral capsule, Sandoz, 500 mg, bottle, 100 count, NDC 00781-2613-01
    • Amoxicillin oral capsule, Sandoz, 500 mg, bottle, 500 count, NDC 00781-2613-05
    • Amoxicillin oral powder for suspension, Sandoz, 125 mg/5 mL, 100 mL bottle, 1 count, NDC 00781-6039-46
    • Amoxicillin oral powder for suspension, Sandoz, 125 mg/5 mL, 150 mL bottle, 1 count, NDC 00781-6039-55
    • Amoxicillin oral powder for suspension, Sandoz, 125 mg/5 mL, 80 mL bottle, 1 count, NDC 00781-6039-58
    • Amoxicillin oral powder for suspension, Sandoz, 200 mg/5 mL, 100 mL bottle, 1 count, NDC 00781-6156-46
    • Amoxicillin oral powder for suspension, Sandoz, 200 mg/5 mL, 50 mL bottle, 1 count, NDC 00781-6156-52
    • Amoxicillin oral powder for suspension, Sandoz, 200 mg/5 mL, 75 mL bottle, 1 count, NDC 00781-6156-57
    • Amoxicillin oral powder for suspension, Sandoz, 250 mg/5 mL, 100 mL bottle, 1 count, NDC 00781-6041-46
    • Amoxicillin oral powder for suspension, Sandoz, 250 mg/5 mL, 150 mL bottle, 1 count, NDC 00781-6041-55
    • Amoxicillin oral powder for suspension, Sandoz, 250 mg/5 mL, 80 mL bottle, 1 count, NDC 00781-6041-58
    • Amoxicillin oral powder for suspension, Sandoz, 400 mg/5 mL, 100 mL bottle, 1 count, NDC 00781-6157-46
    • Amoxicillin oral powder for suspension, Sandoz, 400 mg/5 mL, 50 mL bottle, 1 count, NDC 00781-6157-52
    • Amoxicillin oral powder for suspension, Sandoz, 400 mg/5 mL, 75 mL bottle, 1 count, NDC 00781-6157-57
    • Amoxicillin tablet, Sandoz, 875 mg, 20 count, NDC 00781-5061-20
    • Amoxicillin tablet, Sandoz, 875 mg, 100 count, NDC 00781-5061-01
    • Amoxicillin oral powder for suspension, Teva, 250 mg/5 mL, 150 mL bottle, 1 count, NDC 00093-4155-80
    • Amoxicillin oral powder for suspension, Teva, 250 mg/5 mL, 80 mL bottle, 1 count, NDC 00093-4155-79
    • Amoxicillin oral powder for suspension, Teva, 400 mg/5 mL, 100 mL bottle, 1 count, NDC 00093-4161-73
    • Amoxicillin oral powder for suspension, Teva, 400 mg/5 mL, 75 mL bottle, 1 count, NDC 00093-4161-78
    • Amoxicillin capsule, Teva, 250 mg, bottle, 500 count, NDC 00093-3107-05
    • Amoxicillin capsule, Teva, 500 mg, bottle, 50 count, NDC 00093-3109-53
    • Amoxicillin capsule, Teva, 500 mg, bottle, 500 count, NDC 00093-3109-05
    • Amoxicillin chewable tablet, Teva, 125 mg, bottle, 100 count, NDC 00093-2267-01
    • Amoxicillin tablet, Teva, 500 mg, 100 count, NDC 00093-2263-01

Reason for the Shortage

    • Aurobindo refuses to provide availability information.
    • Hikma is allocating amoxicillin to current customers to meet the planned contracted demand.
    • Rising has amoxicillin capsules and tablets available.
    • Sandoz did not provide a reason for the shortage.
    • Teva did not provide a reason for the shortage.

Available Products

    • Amoxicillin oral capsule, Rising Pharmaceuticals, 250 mg, bottle, 100 count, NDC 57237-0030-01
    • Amoxicillin oral capsule, Rising Pharmaceuticals, 250 mg, bottle, 500 count, NDC 57237-0030-05
    • Amoxicillin oral capsule, Rising Pharmaceuticals, 500 mg, bottle, 100 count, NDC 57237-0031-01
    • Amoxicillin oral capsule, Rising Pharmaceuticals, 500 mg, bottle, 500 count, NDC 57237-0031-05
    • Amoxicillin oral tablet, Rising Pharmaceuticals, 500 mg, bottle, 100 count, NDC 57237-0028-01
    • Amoxicillin oral tablet, Rising Pharmaceuticals, 875 mg, bottle, 20 count, NDC 57237-0029-20
    • Amoxicillin tablet, Rising Pharmaceuticals, 875 mg, 100 count, NDC 57237-0029-01
    • Amoxicillin oral powder for suspension, Teva, 200 mg/5 mL, 100 mL bottle, 1 count, NDC 00093-4160-73
    • Amoxicillin oral powder for suspension, Teva, 200 mg/5 mL, 50 mL bottle, 1 count, NDC 00093-4160-76
    • Amoxicillin oral powder for suspension, Teva, 200 mg/5 mL, 75 mL bottle, 1 count, NDC 00093-4160-78
    • Amoxicillin oral powder for suspension, Teva, 250 mg/5 mL, 100 mL bottle, 1 count, NDC 00093-4155-73
    • Amoxicillin oral powder for suspension, Teva, 400 mg/5 mL, 50 mL bottle, 1 count, NDC 00093-4161-76
    • Amoxicillin capsule, Teva, 250 mg, bottle, 100 count, NDC 00093-3107-01
    • Amoxicillin chewable tablet, Teva, 250 mg, bottle, 100 count, NDC 00093-2268-01
    • Amoxicillin tablet, Teva, 875 mg, 100 count, NDC 00093-2264-01

Estimated Resupply Dates

    • Hikma has all amoxicillin oral presentations on allocation for current customers only.
    • Sandoz has amoxicillin 125 mg/5 mL 100 mL bottles, 200 mg/5 mL 100 mL bottles, and 875 mg tablets in 100 count on back order and the company cannot estimate a release date. All other presentations are available in limited supply.
    • Teva has amoxicillin 250 mg/5 mL 80 mL and 150 mL bottles are on intermittent back order and the company is releasing supplies as they become available. The 400 mg/5 mL in 75 mL and 100 mL bottles are on intermittent back order and the company is releasing product as it becomes available. The 500 mg tablets in 100 count bottles, 125 mg chewable tablets in 100 count bottles, 250 mg capsules in 500 count bottles, and 500 mg capsules in 50 count bottles and 500 count bottles are on intermittent back order and the company is releasing supplies as they become available.

Alternative Agents & Management

    • FDA has issued a guidance document regarding compounding certain beta-lactam products in shortage. This can be found at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/compounding-certain-beta-lactam-products-shortage-under-section-503a-federal-food-drug-and-cosmetic?utm_medium=email&utm_source=govdelivery
    • The American Academy of Pediatrics has antibiotic options for a variety of pediatric conditions at: https://publications.aap.org/redbook/resources/22761?autologincheck=redirected.

Updated

Updated March 17, 2024 by Elyse MacDonald, PharmD, MS, BCPS. Created October 20, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.
ADVERTISEMENT